Suppr超能文献

氧化应激:动静脉内瘘失败过程中的一个关键因素。

Oxidative stress: An essential factor in the process of arteriovenous fistula failure.

作者信息

Hu Ke, Guo Yi, Li Yuxuan, Lu Chanjun, Cai Chuanqi, Zhou Shunchang, Ke Zunxiang, Li Yiqing, Wang Weici

机构信息

Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Cardiovasc Med. 2022 Aug 11;9:984472. doi: 10.3389/fcvm.2022.984472. eCollection 2022.

Abstract

For more than half a century, arteriovenous fistula (AVFs) has been recognized as a lifeline for patients requiring hemodialysis (HD). With its higher long-term patency rate and lower probability of complications, AVF is strongly recommended by guidelines in different areas as the first choice for vascular access for HD patients, and its proportion of application is gradually increasing. Despite technological improvements and advances in the standards of postoperative care, many deficiencies are still encountered in the use of AVF related to its high incidence of failure due to unsuccessful maturation to adequately support HD and the development of neointimal hyperplasia (NIH), which narrows the AVF lumen. AVF failure is linked to the activation and migration of vascular cells and the remodeling of the extracellular matrix, where complex interactions between cytokines, adhesion molecules, and inflammatory mediators lead to poor adaptive remodeling. Oxidative stress also plays a vital role in AVF failure, and a growing amount of data suggest a link between AVF failure and oxidative stress. In this review, we summarize the present understanding of the pathophysiology of AVF failure. Furthermore, we focus on the relation between oxidative stress and AVF dysfunction. Finally, we discuss potential therapies for addressing AVF failure based on targeting oxidative stress.

摘要

半个多世纪以来,动静脉内瘘(AVF)一直被视为需要进行血液透析(HD)患者的生命线。由于其长期通畅率较高且并发症发生率较低,不同地区的指南都强烈推荐将AVF作为HD患者血管通路的首选,其应用比例也在逐渐增加。尽管技术有所改进,术后护理标准也有所提高,但在AVF的使用中仍存在许多不足之处,这与其因成熟失败而无法充分支持HD导致的高失败率以及新生内膜增生(NIH)的发生有关,NIH会使AVF管腔变窄。AVF失败与血管细胞的激活和迁移以及细胞外基质的重塑有关,细胞因子、黏附分子和炎症介质之间的复杂相互作用导致适应性重塑不良。氧化应激在AVF失败中也起着至关重要的作用,越来越多的数据表明AVF失败与氧化应激之间存在联系。在这篇综述中,我们总结了目前对AVF失败病理生理学的认识。此外,我们重点关注氧化应激与AVF功能障碍之间的关系。最后,我们讨论基于靶向氧化应激来解决AVF失败的潜在治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ceb/9403606/e9e11a70943b/fcvm-09-984472-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验